Making sense of breast pathology

Australian Family Physician

Volumn 34, Issue 7, 2005, Pages 581-586

  Bilous, Michael ^a,b   Brennan, Meagan ^b   French, James ^b   Boyages, John ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; BREAST DISEASE; BREAST TUMOR; FEMALE; HUMAN; METHODOLOGY; PATHOLOGY; REVIEW; RISK FACTOR;

BIOPSY; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; RISK FACTORS;

EID: 25144475502     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hutter RVP. Goodbye to 'fibrocystic disease.' N Engl J Med 1985;312:179-81.
2. Rosen PP. Rosen's breast pathology. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 2001.
3. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long term follow up study. Cancer 1985;55:2678-708.
4. Dixon JM, McDonald C, Elton RA, Miller WR. Risk of breast cancer in women with palpable breast cysts: a prospective study. Edinburgh Breast Group. Lancet 1999;353:1742-5.
5. Dixon JM. Cystic disease and fibroadenoma of the breast: natural history and relation to breast cancer risk. Br Med Bull 1991;47:258-71.
6. Harvey JM, Sterrett GF, Frost FA. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis. Pathology 2002;34:410-6.
7. Irfan K, Brem RF. Surgical and mammographic follow up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum assisted biopsy. Breast J 2002;8:230-3.
8. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 1999;85:616-28.
9. Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA, Finkelstein SI, Shepard MJ. Stereotactic, automated large core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long term follow up. Radiology 1999;210:799-805.
10. Claus EB, Stowe M, Carter D, Holford T. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry. Breast 2003;12:451-6.
11. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol 2002;26:1095-110.
12. Viale G. Histopathology of primary breast cancer 2003. Breast 2003;12:391-6.
13. Australian Cancer Network Working Party. The pathology reporting of breast cancer: a guide for pathologists, surgeons, radiologists and oncologists. 2nd ed. Sydney, 2001.
14. Boyages J, Connolly JL, Schnitt SJ, Harris JR. Definition of an extensive intraductal component. In: The Pathology Reporting of Breast Cancer. Australian Cancer Network. CAN Publication No. 2;66-78.